- Home
- Services
- Drug Delivery Nanoparticles Formulation
-
Liposomes Production
- Pharmacosomes Production
- PEGylated Liposomes Production
- Conventional Liposomes Production
- Solid Lipid Nanoparticle Production
- Transfersomes and Ethosomes Production
- Immunoliposomes (Ligand-Targeted Liposomes) Production
- Cationic Nanoemulsions Production
- Lipid Nanoparticle Production
- Nanostructured Lipid Carriers Production
- Lipoplexes Production
-
Polymeric Nanoparticles Production
-
Peptide-Based Drug Delivery Systems
-
Viral Vector-Based Delivery System
-
Exosomes Production
-
Porous Organic Frameworks (POFs) and Drug Load Customization
-
Protein-based Nanoparticles Production
-
Living Cell-Based Drug Delivery Systems
- Nanocages Production
- Metallic Nanoparticles Production
- Carbon-based Nanocages Production
-
- Other Types of Drug Delivery
-
Rapid-Released Microneedle Patches-Based Drug Delivery System
-
Transdermal Patches-Based Drug Delivery System
-
Freeze-dried Flash Release Tablets Based Drug Delivery System
-
pH Responsive Capsules-Based Drug Delivery System
-
Microencapsulation-Based Drug Delivery System
- Sustained-Release Microspheres
- Wound Dressings-Based Drug Delivery System
- Drug-Loaded Contact Lens-Based Drug Delivery System
- Multiparticulate System-Based Drug Delivery System
- Polymeric Films-Based Drug Delivery System
- Controlled-Release Implant-Based Drug Delivery System
- Silica-Based Drug Delivery System
- Swellable hydrogel-Based Drug Delivery System
-
- Bioparticles Analysis and Characterization
- mRNA-LNP Vaccine Laboratory Process Development Assay
- Toxicity Measurement
- Drug In Vitro Testing
- Lamellarity Determination
- Drug Localization Analysis
- Bioparticles Stability Studies
- Bioparticle Component Analysis
- Bioparticles Zeta Potential Analysis
- Bioparticle Size and Morphology Analysis
- Pharmacodynamics and Pharmacokinetics Test
- Bioparticles Penetration and Permeation Test
- Bioparticles Encapsulation Efficiency Analysis
- In Vivo Fates Prediction Study
- Bioimaging Services for Nanoparticles
- Animal Model Construction
- Animal Models Evaluation
- Protein Binding Affinity Analysis on Artificial Lipid Droplets
- Aptamer Targeted Drug Delivery System
- Functional Biomedical Coatings
- Lipid Library Development for Drug Delivery
- Antimicrobial Lipid Nanoparticles Formulation, Development, and Function Evaluation
- Barcoded nanoparticles (NPs) development for high-throughput in vivo analysis
- Lipid Nanoparticle Formulation and Development for mRNA Vaccine Delivery
- Organelle & Cell & Tissue Targeting Liposomes Formulation and Development
- Formulation Process Development
- Drug Targeting Strategy
- Bioactive Particles & Fillers Production
- Drug Delivery Nanoparticles Formulation
- Products
- Biopolymers & Synthetic Polymers
-
Low PDI Polymers
- Polyacrylamide
- Polyolefin Family
- Polystyrene Family
- Polysiloxane Family
- Polylactides Family
- Poly(ethylene glycol)
- Polycaprolactone Family
- Other Hydrophilic Polymers
- Fused Heterocycle Polymers
- Diblock Copolymers, AB-type
- Other Hydrophobic Homopolymers
- Triblock Copolymers, ABC-type or ABA-type
- Poly(vinyl amide) and Poly(vinyl amine) Families
- Poly([alkyl] acrylic acid) and Poly([alkyl] methacrylate) Families
- Poly(dimethylsiloxane)
-
Biodegradable Polymers
- Agar
- Pectin
- Ficolls
- Agarose
- Dextrans
- Dendrons
- Heparins
- Chitosans
- Poly(THF)
- Alginates
- Celluloses
- Dendrimers
- Xanthan Gum
- Carrageenans
- Polylactides
- Alginic Acids
- D-Glucosamines
- Other Polymers
- Locust Bean Gum
- Hyaluronic Acids
- Poly(glycolide)s
- Poly(caprolactone)s
- Chondroitin Sulfates
- Poly(propylene glycol)
- Other Polysaccharides
- Poly(methyl methacrylate)
- Oligomeric Hyaluronic Acids
- Poly(Lactide-co-caprolactone)s
- Poly(lactic-co-glycolic acid)s
- Poly(glycolide-co-caprolactone)s
- Poly(N-isopropylacrylamide) Copolymers
- Poly(lactide-co-trimethylene carbonate)s
- Block Copolymer Micelles
- PEG Conjugations
- Monomers
-
Fluorescent Polymers
- Fluorescent Heparins
- Fluorescent Dextrans
- Fluorescent Alginates
- Fluorescent Chitosans
- Fluorescent Celluloses
- Fluorescent Lipid PEGs
- Fluorescent Polylactides
- Fluorescent Polyamino Acid
- Fluorescent Hyaluronic Acids
- Fluorescent Triblock Copolymers
- Fluorescent Chondroitin Sulfates
- Fluorescent AB Diblock Copolymers
- Fluorescent Monodispersed Linear PEGs
- Fluorescent Monofunctional Linear PEGs
- Fluorescent Oligomeric Hyaluronic Acids
- Fluorescent Heterobifunctional Linear PEGs
- Fluorescent Poly(lactic-co-glycolic acid)s
- Polyamino acids
- Cyclodextrin
- Polyorthoester
- PVP-Maleate Copolymers
- PEOT/PBT multi-block Copolymers
- Polyhydroxybutyrate
- PEG Polyamino Acids
- Polyamino Acids-PLGA
- Enviromental responsive copolymers
-
Low PDI Polymers
- Porous Organic Materials
- RAFT Reagents
- MOF Initiators
- Functional Materials
- Catalyst & Ligands
-
Metal-organic Frameworks (MOFs) Linkers
- Multi-Carboxylic MOFs Linkers
- 2d-Carboxylic MOFs Linkers
- 3d-Carboxylic MOFs Linkers
- 4d-Carboxylic MOFs Linkers
- Multi-Nitrogen MOFs Linkers
- 2d-Nitrogen MOFs Linkers
- 3d-Nitrogen MOFs Linkers
- Multi-Hybrid MOFs Linkers
- 2d-Hybrid MOFs Linkers
- 3d-Hybrid MOFs Linkers
- A2B2-Porphyrins
- A3B1-Porphyrins
- A4-Porphyrins
- Bipyridine Blocks
- Halide Substituted Aromatics
- Metalloporphyrins
- Tetraphenylethylene
- Triphenylbenzene
- Customizable MOFs Linkers
- Isophthalate
- Other MOFs Linkers
- Other Organic-Linker Blocks
-
Covalent Organic Framework (COFs) Linkers
- Multi-Nitrile COFs Linkers
- 2d Boric COFs Linkers
- 3d-Boric COFs Linkers
- 4d-Boric COFs Linkers
- 2d Nitrile COFs Linkers
- 3d Nitrile COFs Linkers
- Acetonitrile COFs Linkers
- Multi-Aldehyde COFs Linkers
- 2d-Aldehyde COFs Linkers
- 3d-Aldehyde COFs Linkers
- Multi-Alkyne Orgnic COFs Linkers
- 2d-Alkyne Orgnic COFs Linkers
- 3d-Alkyne Orgnic COFs Linkers
- Multi-Phosphoric Acids COFs Linkers
- 2d-Phosphoric Acids COFs Linkers
- 3d-Phosphoric Acids COFs Linkers
- Multi-Amine COFs Linkers
- 2d-Amine COFs Linkers
- Hybrid COFs Linkers
- Customizable COFs Linkers
- Other COFs Linkers
-
Metal-organic Frameworks (MOFs) Materials
- Iron-based MOFs (Fe-MOF)
- Zinc-Based MOFs (Zn-MOF)
- Cerium-based MOFs (Ce-MOF)
- Cobalt-based MOFs (Co-MOF)
- Nickel-based MOFs (Ni-MOF)
- Indium-based MOFs (In-MOF)
- Vanadium-based MOFs (V-MOF)
- Titanium-based MOFs (Ti-MOF)
- Chromium-based MOFs (Cr-MOF)
- Aluminum-based MOFs (Al-MOF)
- Copper-based MOFs (Cu–MOF)
- Manganese-based MOFs (Mn-MOF)
- Magnesium-based MOFs (Mg-MOF)
- Zirconium-based MOFs (Zr-MOF)
- Covalent Organic Framework (COF) Materials
- Hydrogen-bonded Organic Framework (HOF) Materials
- Transfection
- Chelating Agents
- Liposome System
- Bioactive Matrixes
- Cleavable Linkers
- PROTAC
- Exosome Products
- Tissue Engineering Scaffold
- Excipients
- Functional Ingredients
- Lipids
- Biopolymers & Synthetic Polymers
- Technology
- Cargos
- Nanoparticles for Therapeutic Cargos —Vaccines
- Nanoparticles for Therapeutic Cargos — Nucleic Acids
- Nanoparticles for Therapeutic Cargos — Protein Drugs
- Nanoparticles for Therapeutic Cargos — Small Molecule Drugs
- Nanoparticles for Therapeutic Cargos-Virus
- Nanoparticles for Therapeutic Cargos-Health Products
- Nanoparticles for Therapeutic Cargos-Fluorescent Dyes
- Nanoparticles for Therapeutic Cargos-Flavors and Fragrances
- Nanoparticles for Therapeutic Cargos-Cosmetics
- Applications
- Nanoparticles for Medical Devices
- Nanoparticles for Cancer Treatment
- Nanoparticles for Medical Diagnostics
- Nanoparticles for Neurological Disease Treatment
- Nanoparticles for Cardiovascular Disease Treatment
- Nanoparticles for Dietary Supplements
- Nanoparticles for Food Industry
- Nanoparticles for Skin Care and Cosmetics
- Nanoparticles for Textiles
- Nanoparticles for Catalysts
- Nanoparticles for Agricultural Industry
- Routes of Delivery
- Delivery Vehicles
- Nanoparticles for Therapeutic Vehicles-Polymer Micelles
- Nanoparticles for Therapeutic Vehicles-Liposomes
- Nanoparticles for Therapeutic Vehicles-Exosomes
- Nanoparticles for Therapeutic Vehicles-Dendrimers
- Nanoparticles for Therapeutic Vehicles-Biodegradable Polymers
- Nanoparticles for Therapeutic Vehicles-Carbon Nanotubes
- Nanoparticles for Therapeutic Vehicles-Hydrogels
- Nanoparticles for Therapeutic Vehicles-Cyclodextrin
- Nanoparticles for Therapeutic Vehicles-Superparamagnetic Iron Oxide Nanoparticles
- Nanoparticles for Therapeutic Vehicles-Gold Nanoparticles
- Nanoparticles for Therapeutic Vehicles-Mesoporous Silica Particles
- Nanoparticles for Therapeutic Vehicles-Metal Organic Frame
- Nanoparticles for Therapeutic Vehicles-Quantum Dots
- Nanoparticles for Therapeutic Vehicles-HOFs
- Nanoparticles for Therapeutic Vehicles-DNA Origami
- Nanoparticles for Therapeutic Vehicles-Aptamer
- Nanoparticles for Therapeutic Vehicles-COFs
- Nanoparticles for Therapeutic Vehicles-Microemulsion & Self-Microemulsion
- Organ
- Bone-Targeted Drug Delivery Systems
- CNS-Targeted Drug Delivery Systems
- Kidney-Targeted Drug Delivery Systems
- Liver-Targeted Drug Delivery Systems
- Lung-Targeted Drug Delivery Systems
- Adipose-Targeted Drug Delivery Systems
- Gastrointestinal-Targeted Drug Delivery Systems
- Tumor-Targeted Drug Delivery Systems
- Muscles-Targeted Drug Delivery Systems
- Cargos
- Supports
- Company
- Online Order
Datasheet![2,2′,2”-(10-(4-((2-((((1R,8S,9s)-bicyclo[6.1.0]non-4-yn-9-ylmethoxy)carbonyl)amino)ethyl)amino)-1-carboxy-4-oxobutyl)-1,4,7,10-tetraazacyclododecane-1,4,7-triyl)triacetic acid](/productimages/BCN-DOTA-GA.jpg)
ester.jpg)
ethanamide.jpg)
ethanamide.jpg)
ester.jpg)
ester.jpg)
